This study confirmed equivalent efficacy among amisulpride and CBD (Positive and Damaging Syndrome Scale [PANSS], Short Psychiatric Ranking Scale [BPRS]). A possible edge for CBD is its milder side effects: less extrapyramidal signs or symptoms, much less bodyweight gain, and no hyperprolactinemia.65 Contrary into the effects of THC, many preclinical https://onlinethcaflower45558.ssnblog.com/31984841/thc-concentrates-no-further-a-mystery